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Congenital heart disease (CHD), affects 1% of all 
live births and is the leading noninfectious cause of 
death in the 1st year of life[1]. With the progress in 
molecular genetics and developmental biology, genes 
associated with heart disease have been identified[2]. It 
is found that single nucleotide polymorphisms (SNPs) 
in a variety of single genes are associated with 
congenital heart defects and genetic syndromes[2]. 
Data from mouse and human demonstrated that the 
zinc finger containing transcription factor (GATA4) 
plays a critical role in heart disease development[3]. 
GATA4 interacts directly with NKX2.5 via the 
homeodomain of NKX2.5 and zinc finger domain 
of GATA4. Further, regulates genes involved in 
embryogenesis and in myocardial differentiation and 
function[3]. Mutations in GATA4 has been identified 
in multiplex families like septal defects, such as atrial 
septal defect (ASD), and ventricular septal defect 
(VSD)[4].
Molecular genetic testing of GATA4 mutations is 
more widespread and applied clinically. These testing 
are the basis for improved diagnosis and therapy of 
human CHD. To discriminate between synonymous 
SNPs (sSNPs), which constitute the majority of 
genetic variation and nonsynonymous SNPs (nsSNPs) 
located in coding regions, an analysis of DNA and 
protein sequence would result in amino acid variation 
in the protein products of genes[5].
Earlier studies from our laboratory revealed the 
prevalence of CHDs ranging from 6.6 to 13.06 per 
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1000 live births in India[6]. Among the different 
CHDs and VSDs were the most common phenotype 
observed with high rate of consanguinity in the 
patient families[7]. Studies from our laboratory also 
reported numerical and structural chromosomal 
anomalies[8]. However, molecular studies on CHDs 
are limited. In light of this, we have screened SNPs 
of GATA4 in 100 CHD patients and 50 controls in 
south Indian population and found 11 nsSNPs namely 
c.1129A>G (S377G), c.1180C>A (P394T), c.1081A>G 
(M361V), c.1138G>A (V380M), c.1273G>A (D425N), 
c.716A>G (N239S), c.278G>C (G93A), c.1207C>A 
(L403M), c.1232C>T (A411V), c.1295T>C (L432S) 
and novel SNP, c.1180C>G (P394A)[9].
Further, in silico analysis of these SNPs is very 
limited in exploring the molecular mechanisms of 
CHD. In view of this, an attempt to analyse the 
nsSNPs of GATA4, which are involved in CHD 
was made using in silico tools to predict structural 
changes in the protein as well as quantitative and 
qualitative evaluation of the protein.
MATERIALS AND METHODS
The present study was conducted at Genomics 
Laboratory, Department of Studies in Zoology, 
University of Mysore, Karnataka, India between 
September 2007 and March 2013.
Secondary structure analysis:
Forty nine nsSNPs of GATA4 cited in literature was 
used in this study, of which 11 nsSNPs reported from 
our laboratory is also included[4,10-21]. All 49 sequences 
were mutated in silico to generate nsSNPs. These 
sequences were translated to identify amino acid 
polymorphisms. The differences in protein sequences 
were compared through multiple sequence alignment. 
The secondary structures for all the 49 nsSNPs have 
been predicted by Chou Fasman secondary structure 
algorithm by using Accelrys gene software[22].
Comparative modeling of GATA4 nsSNPs:
Mutational effect on protein structure was determined 
by using http://swissmodel.expasy.org/workspace[23]. 
Template structures N-terminal zinc finger of murine 
GATA-1 protein (PDB Id: 1GNF_A) between 213-251 
residues and opposite GATA DNA binding protein 
(PDB Id: 3DFX_B) between 265-320 residues was 
used to generate 3-D structures[24]. The 19 nsSNPs of 
these regions were analysed. The root-mean-square 
deviation (RMSD) calculation for all the modeled 
structure to the template found the difference from 
0.01 to 0.015[23].
Evaluation and validation of three-dimensional 
structure:
Evaluation and validation of the 3-D structure was 
done using VADAR server (Alberta, Canada)[25]. 
The overall quality of the modeled protein was 
assessed by Ramachandran plot[25]. The structure 
superimposition of both control and mutant proteins 
was performed using Pymol[26].
RESULTS
Only 16 nsSNPs of GATA4 showed positive in 
their secondary structure change (Table 1). These 
changes with reference to control are represented in 
fig. 1. The proteins derived from nsSNPs of GATA4, 
c.755G>C, c.1037C>T, c.1129A>G and c.1130G>A 
showed changes in their turn, c.155C>T, c.487C>T 
and c.1220C>A showed changes in their sheet and 
mutation c.278G>C showed changes only in helix. 
The nsSNP of GATA4, c.687G>T was responsible 
to change either into sheet or helix. The GATA4 
nsSNPs, c.779G>A and c.855T>C may change 
to helix or turn. The changes in helix or sheet 
was observed at c17C>T, c.82C>T, c.905A>G and 
c.1207C>A. Mutation at c.1295T>C showed changes 
in their helix, sheet or turn.
Two X-ray crystallographic structures showed 
homology to GATA4 protein. The N-terminal 
Zinc finger protein of GATA4 had homology with 
N-terminal zinc finger of murine GATA-1 protein 
(PDB Id: 1GNF_A) and with opposite GATA DNA 
binding protein (PDB Id: 3dfxB). For validation 
of modeling Ramachandran plot was applied using 
VADAR server (Alberta, Canada) (fig. 2).
Tertiary structural changes are showed in 
figs. 3 and 4. Since the tertiary structural are 
modeled using Homology modeling only side chain 
differences compared to control protein were observed 
(figs. 3 and 4). We observed differences in the side 
chain atoms such as, Delta carbon (CD), epsilon 
nitrogen (NE), zeta carbon (CZ), gamma carbon 
(CG), gamma sulphur (SG), gamma oxygen (OG1), 
delta sulphur (SD). The Quantitative and qualitative 
analysis of GATA4-mutated proteins showed, 
differences in free energy of folding, volume and 
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accessible surface area (ASA) with control protein 
(Table 2).
DISCUSSION
Human SNPs represent the most frequent type of 
DNA variation. The main goals of SNP research is 
to understand the genetics of the human phenotype 
variation and especially the genetic basis of human 
complex diseases[5]. The nsSNPs comprise a group 
of SNPs that together with SNPs in regulatory 
regions are believed to have the highest impact on 
phenotype[27]. The nsSNPs also known as single 
amino acid polymorphism (SAPs) that causes amino 
acid changes in proteins, which have the potential to 
affect both protein structure and function[28]. Some 
of the mutations in SAP sites are not associated 
with any changes in phenotype and are considered 
functionally neutral, but others bringing deleterious 
effects to protein function and are responsible for 
many human genetic diseases[28]. By the analysis of 
the new incoming data on SNPs by mapping them 
at sequence and structural would address problems 
concerning population, medical and evolutionary 
genetics[29].
Reamon-Buettner and Borlak[11] reported that, zinc 
finger transcription factor, GATA4 is a master 
regulator of heart development. Zinc finger mutation 
identified in this gene affects a zinc coordinating 
cysteine in the C-terminal finger and is strongly 
associated with VSDs. GATA4 zinc finger mutations 
are shown to affect DNA binding, contacts on zinc 
ion and protein secondary structure. The impaired 
GATA4 interaction with the third helix of the 
homeodomain of NKX2.5 results in septation defects 
of the human heart[11].
The structural changes in the analysed GATA4 
mutated protein might be responsible for non 
functional GATA4 proteins. However, we found 
only side chain differences of the amino acids at the 
tertiary structure level of protein. Theoretical accuracy 
of prediction of the tertiary structure of a protein from 
a sequence is 90%[30]. Local conformation of a protein 
varies under the native conditions. These limitations 
are also imposed by secondary structure prediction’s 
inability to account for tertiary structure. The only 
one amino acid difference occurs by particular nsSNP 
TABLE 1: NONSYNONYMOUS SNPS OF GATA4 AND 
THEIR IMPACT ON SECONDARY STRUCTURE OF 
PROTEIN
SNP Amino acid 
change
Secondary structure of 
the protein
Helix Sheet Turn
c.17C>T A6V + + −
c.82C>T H28Y + + −
c.155C>T S52F − + −
c.278G>C G93A + − −
c.454G>C A152P − − −
c.487C>T P163S − + −
c.622T>C F208L − − −
c.631T>C F211L − − −
c.640G>A G214S − − −
c.648C>G E216D − − −
c.668T>C M223T − − −
c.687G>T R229S − + +
c.700G>A G234S − − −
c.715A>G N239D − − −
c.716A>G N239S − − −
c.731A>G Y244C − − −
c.743A>G N248S − − −
c.755G>C R252P − − +
c.764T>C I255T − − −
c.779G>A R260Q + − +
c.782T>C L261P − − −
c.796C>T R266X − − −
c.818A>G N273S − − −
c.830C>T T277I − − −
c.848G>A R283H − − −
c.855T>C N285K + − +
c.874T>C C292R − − −
c.881C>T A294V − − −
c.886G>T G296C − − −
c.886G>A G296S − − −
c.905A>G H302R + + −
c.946C>G Q316E − − −
c.1037C>T A346V − − +
c.1075G>A E359K − − −
c.1081A>G M361V − − −
c.1129A>G S377G − − +
c.1130G>A S377N − − +
c.1138G>A V380M − − −
c.1180C>A P394T − − −
c.1207C>A L403M + + −
c.1220C>A P407Q − + −
c.1232C>T A411V − − −
c.1273G>A D425N − − −
c.1286G>C S429T − − −
c.1288C>G L430V − − −
c.1295T>C L432S + + +
c.1306C>T H436Y − − −
c.1324G>A A442T − − −
c.1325C>T A442V − − −
+: The secondary structure changes of the GATA4 protein
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and modeling tool considers the same template for all 
nsSNPs. Hence, all models have same structure except 
side chain difference for the mutated.
Side chain of an amino acid is specific to each 
amino acid of a protein. The side chain can make 
an amino acid as a weak acid or a weak base, and a 
hydrophile if the side chain is polar or a hydrophobe 
if it is nonpolar[31]. The distribution of hydrophilic 
and hydrophobic amino acids determines the tertiary 
structure of the protein. There physical location of 
proteins influences their quaternary structure[31]. These 
Fig. 1: Secondary structure of GATA4 mutated proteins.
Secondary structure of GATA4 mutated proteins derived from 16 nsSNPs shows structural changes in their helix (blue), sheet (green) and 
turn (red) compare to normal protein of GATA4.
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Fig. 2: Ramachandran plot.
Ramachandran plot was analysed using Volume Area Dihedral Angle Reporter server (Alberta, Canada) for the evaluation and validation 
of 3-D reference structures: (a) n-terminal zinc finger of murine GATA-1 protein (PDB Id: 1gnfA): fully allowed region (41 residues, 78.85%), 
additionally allowed region (10 residues, 19.23%), outside region (1 residue GLY24, 1.92%) (b) opposite GATA DNA binding protein (PDB 
Id: 3dfxB): Fully allowed region (20 residues, 4.05%), additionally allowed region (14 residues, 37.84%), generously allowed region (2 residues 
GLY2, GLY37, 5.41%), outside region (1 residue ASN27, 2.70%).
ba
Fig. 3: 3-D models of mutated proteins derived from 9 nsSNPs of 
zinc finger region of GATA4.
Each model was superimposed by control (left side of each image) and 
mutated protein (right side of each image). Models were done using 
solution structure of the n-terminal zinc finger of murine GATA-1 
(PDB Id: 1gnfA) and also for mutant. Ball and stick representation 
in both the models showed the side chain structural differences 
between control and mutated proteins. (a) E216D: In control- Delta 
Carbon (CD), Epsilon Oxygen (OE1, OE2) and in mutant OD1, OD2. 
(b) G214S: In control-no changes and in mutant Gamma Carbon (CG), 
Gamma Oxygen (OG). (c) M223T: In control- CB, CG, Delta Sulphur 
(SD), CE and in mutant CG2, OG1. (d) R229S: In control- CG, CD, 
Epsilon Nitrogen (NE), CE2, Zeta Carbon (CZ). NH1, NH2 and in 
mutant OG. (e) G234S: In control- no changes and in mutant CB, 
OG. (f) N239D: In control-ND2, OD1 and in mutant OD1, OD2. (g) 
N239S: In control- CG, ND2, OD1 and in mutant OG. (h) Y244C: In 
control- CG, CD1, CD2, CE1, CZ, OH and in mutant Gamma Sulphur 
(SG). (i) N248S: In control- CG, ND2, OD1and in mutant OG.
b
d
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Fig. 4: 3-D models of mutated proteins derived from 10 nsNPs of 
GATA4.
Each model was superimposed by control (left side of each image) 
and mutated protein (right side of each image). Models were done 
using solution structure of the opposite GATA DNA binding protein 
(PDB Id: 3dfxB) and also for mutant. Ball and stick representation in 
both the models showed the side chain structural differences between 
control and mutated proteins. (a) T277I: In control-CG2, OG1and in 
mutant CG1, CG2, CD1. (b) R283H: In control- CD, NE, CZ, NH1, 
NH2 and in mutant CD2, ND1, CE1, NE2. (c) Q316E: In control-NE2, 
OE1 and in mutant OE1, OE2. (d) N285K: In control-ND2, OD1 and 
in mutant CD, CE, NZ. (e) N273S: In control-CG, ND2, OD1 and in 
mutant OG. (f) C292R: In control-SG and in mutant CG, CD, NE, 
CZ, NH1, NH2. (g) A294V: In control- no changes and in mutant 
CG1, CG2. (h) G296C: In control-no changes and in mutant CB, SG 
(i) G296S: In control-no changes and in mutant CB, OG. (j) H302R: In 
control-CD2, ND1, CE1, NE2 and in mutant CD, NE, CZ, NH1, NH2.
b
f
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properties are important in protein structure and 
protein–protein interactions[31].
Accessible surface area (ASA) is the exposed surface 
area of the protein (or residue) that a water molecule 
could access or touch. ASA of the side chain values 
are also calculated for polar (N, O, S) atoms, charged 
atoms (N, O) and for nonpolar atoms (C) to permit 
the calculation of polar, charged and nonpolar surface 
area. These ASA values can be quite useful in 
structure assessment and thermodynamic calculations. 
ASA is highly dependent on the choice of atomic or 
van der Waals radii. Protein structures are stabilized 
by hydrophobic and van der Waals forces, and by 
hydrogen bonds. Hydrophobic energy is gained by 
the reduction of surface in contact with water[32]. In 
the present study, we observed differences in free 
energy of folding and volume of the protein. There 
is a linear relationship between the solvation free 
energy of folding and the protein size and misfolded 
structures showed higher solvation free energies[33].
Usually nsSNP do not inactivate protein functionality 
completely, instead, nsSNPs change the protein 
activity at some level, either directly or indirectly 
through interactions with other proteins in the 
pathway. Such information has to be considered 
mutually[34]. Therefore, side chain differences of the 
amino acids in the 3-D structure of GATA4 mutated 
protein may be responsible for nonfunctioning 
of GATA4 proteins. This study will facilitate to 
further study structural changes and distinguish 
the CHD-causing nsSNPs from neutral SNPs. This 
information will explore further for probing and 
utilization in pharmacogenetics study and also in 
biomedical applications.
Acknowledgments:
We are grateful to all the patients families participated 
in this investigation, Doctors and PG students 
for their kind support, Professor and Chairman, 
DOS in Zoology, University of Mysore, Mysore, 
Unit on Evolution and Genetics for the laboratory 
facilities and also Prof. H. A. Ranganath for his 
encouragement.
Financial support and sponsorship:
We thank Council for Scientific and Industrial 
Research (CSIR), New Delhi, Government of India 
[No.27 (0156)/06/EMR-II dated 19.10.2006] for the 
financial support.
Conflicts of interest:
There are no conflicts of interest.
REFERENCES
1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am 
Coll Cardiol 2002;39:1890-900.
2. Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular 
mechanisms of congenital heart disease. Cardiovasc Pathol 
2010;19:e183-93.
3. Sander TL, Klinkner DB, Tomita-Mitchell A, Mitchell ME. Molecular 
and cellular basis of congenital heart disease. Pediatr Clin North Am 
2006;53:989-1009.
4. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, 
et al. GATA4 mutations cause human congenital heart defects and 
reveal an interaction with TBX5. Nature 2003;424:443-7.
5. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: 
Server and survey. Nucleic Acids Res 2002;30:3894-900.
6. Smitha R, Karat SC, Narayanappa D, Krishnamurthy B, Prasanth SN, 
Ramachandra NB. Prevalence of congenital heart diseases in Mysore. 
Int J Hum Genet 2006;12:12-7.
7. Ramegowda S, Ramachandra NB. Parental consanguinity 
increases congenital heart diseases in South India. Ann Hum Biol 
2006;33:519-28.
TABLE 2: SUMMARY OF FREE ENERGY OF FOLDING 
AND VOLUME AND ACCESSIBLE SURFACE AREA
SAP ASA in Angs 2
Control (213–251)= 
66.6
Volume of the 
protein (Angs 3)
Control (213–251)= 
4618.1
Free energy of 
folding (kcal/mol)
Control (213–251)= 
−28.00
E216D 69.2 4598.5 −27.71
G214S 49.6 4644.4 −27.93
G234S 63.3 4644.9 −27.82
M223T 51.4 4577.4 −27.02
N239D 90.2 4619.6 −27.93
N239S 59.9 4587.6 −27.47
N248S 33.8 4602.6 −27.81
R229S 70.3 4551.6 −27.81
Y244C 42.8 4504.0 −28.00
ASA in Angs 2
Control (265–320)= 
77.5
Volume of the 
protein (Angs 3)
Control (265–320)= 
6448.4
Free energy of 
folding (kcal/mol)
Control (265–320)= 
−32.15
T277I 79.6 6459.3 −32.64
R283H 48.0 6418.2 −33.19
Q316E 117.4 6455.0 −31.32
N285K 57.5 6513.6 −33.31
N273S 23.2 6430.3 −32.09
H302R 113.4 6469.1 −32.35
G296S 17.8 6472.3 −32.32
C292R 27.4 6985.4 −29.98
G296C 23.1 6485.1 −32.82
A294V 67.4 (42.9) 7008.4 −32.32
Differences in free energy of folding, volume and ASA with control protein. ASA 
of control is mentioned in parenthesis. ASA: Accessible surface area, SAP: single 
amino acid polymorphism
November - December 2015 Indian Journal of Pharmaceutical Sciences 741
www.ijpsonline.com
8. Smitha R, Harshavardhan MG, Hyderi A, Savitha MR, Krishnamurthy B, 
Karat SC, et al. Chromosomal anomalies and congenital heart disease in 
Mysore, South India. Int J Hum Genet 2010;10:131-9.
9. Dinesh SM, Lingaiah K, Savitha MR, Krishnamurthy B, 
Narayanappa D, Ramachandra NB. GATA4 specific nonsynonymous 
single-nucleotide polymorphisms in congenital heart disease patients of 
Mysore, India. Genet Test Mol Biomarkers 2011;15:715-20.
10. Hirayama-Yamada K, Kamisago M, Akimoto K, Aotsuka H, Nakamura Y, 
Tomita H, et al. Phenotypes with GATA4 or NKX2.5 mutations in 
familial atrial septal defect. Am J Med Genet A 2005;135:47-52.
11. Reamon-Buettner SM, Borlak J. GATA4 zinc finger mutations as a 
molecular rationale for septation defects of the human heart. J Med 
Genet 2005;42:e32.
12. Sarkozy A, Conti E, Neri C, D’Agostino R, Digilio MC, Esposito G, 
et al. Spectrum of atrial septal defects associated with mutations of 
NKX2.5 and GATA4 transcription factors. J Med Genet 2005;42:e16.
13. Nemer G, Fadlalah F, Usta J, Nemer M, Dbaibo G, Obeid M, et al. A 
novel mutation in the GATA4 gene in patients with tetralogy of fallot. 
Hum Mutat 2006;27:293-4.
14. Zhang L, Tümer Z, Jacobsen JR, Andersen PS, Tommerup N, 
Larsen LA. Screening of 99 Danish patients with congenital heart 
disease for GATA4 mutations. Genet Test 2006;10:277-80.
15. Rajagopal SK, Ma Q, Obler D, Shen J, Manichaikul A, 
Tomita-Mitchell A, et al. Spectrum of heart disease associated with 
murine and human GATA4 mutation. J Mol Cell Cardiol 2007;43:677-85.
16. Reamon-Buettner SM, Cho SH, Borlak J. Mutations in the 
3’-untranslated region of GATA4 as molecular hotspots for congenital 
heart disease (CHD). BMC Med Genet 2007;8:38.
17. Schluterman MK, Krysiak AE, Kathiriya IS, Abate N, Chandalia M, 
Srivastava D, et al. Screening and biochemical analysis of GATA4 
sequence variations identified in patients with congenital heart disease. 
Am J Med Genet A 2007;143A:817-23.
18. Posch MG, Perrot A, Schmitt K, Mittelhaus S, Esenwein EM, Stiller B, 
et al. Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are 
infrequently found in patients with congenital cardiac septal defects. 
Am J Med Genet A 2008;146A:251-3.
19. Zhang W, Li X, Shen A, Jiao W, Guan X, Li Z. GATA4 mutations in 
486 Chinese patients with congenital heart disease. Eur J Med Genet 
2008;51:527-35.
20. Hamanoue H, Rahayuningsih SE, Hirahara Y, Itoh J, Yokoyama U, 
Mizuguchi T, et al. Genetic screening of 104 patients with congenitally 
malformed hearts revealed a fresh mutation of GATA4 in those with 
atrial septal defects. Cardiol Young 2009;19:482-5.
21. Zhang WM, Li XF, Ma ZY, Zhang J, Zhou SH, Li T, et al. GATA4 and 
NKX2.5 gene analysis in Chinese Uygur patients with congenital heart 
disease. Chin Med J (Engl) 2009;122:416-9.
22. Al-Ali H, Khachfe HM. The N-terminal domain of apolipoprotein 
B-100: Structural characterization by homology modeling. BMC 
Biochem 2007;8:12.
23. Kopp J, Schwede T. The SWISS-MODEL Repository of annotated 
three-dimensional protein structure homology models. Nucleic Acids 
Res 2004;32:D230-4.
24. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: 
An environment for comparative protein modeling. Electrophoresis 
1997;18:2714-23.
25. Willard L, Ranjan A, Zhang H, Monzavi H, Boyko RF, Sykes BD, 
et al. VADAR: A web server for quantitative evaluation of protein 
structure quality. Nucleic Acids Res 2003;31:3316-9.
26. Bramucci E, Paiardini A, Bossa F, Pascarella S. PyMod: Sequence 
similarity searches, multiple sequence-structure alignments, and homology 
modeling within PyMOL. BMC Bioinformatics 2012;13 Suppl 4:S2.
27. Våge J, Lingaas F. Single nucleotide polymorphisms (SNPs) in coding 
regions of canine dopamine- and serotonin-related genes. BMC Genet 
2008;9:10.
28. Hu J, Yan C. Identification of deleterious non-synonymous single 
nucleotide polymorphisms using sequence-derived information. BMC 
Bioinformatics 2008;9:297.
29. Sunyaev S, Lathe W 3rd, Bork P. Integration of genome data and 
protein structures: Prediction of protein folds, protein interactions and 
“molecular phenotypes” of single nucleotide polymorphisms. Curr Opin 
Struct Biol 2001;11:125-30.
30. Saunders R, Deane CM. Protein structure prediction begins well but 
ends badly. Proteins 2010;78:1282-90.
31. Creighton TE. Proteins: Structures and Molecular Properties. Ch. 1. San 
Francisco: WH Freeman; 1993.
32. Miller S, Lesk AM, Janin J, Chothia C. The accessible surface area and 
stability of oligomeric proteins. Nature 1987;328:834-6.
33. Chiche L, Gregoret LM, Cohen FE, Kollman PA. Protein model 
structure evaluation using the solvation free energy of folding. Proc 
Natl Acad Sci U S A 1990;87:3240-3.
34. Uzun A, Leslin CM, Abyzov A, Ilyin V. Structure SNP (StSNP): 
A web server for mapping and modeling nsSNPs on protein 
structures with linkage to metabolic pathways. Nucleic Acids Res 
2007;35:W384-92.
